Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Otherwise healthy male subjects age 45 years or older with or without erectile dysfunction.~Body Mass Index (BMI) of 17.5 to 32.5 kg/m2.~Signed and dated informed consent document.~Exclusion Criteria:~* Evidence or history of clinically significant abnormalities~* Have baseline orthostatic hypotension~* Positive drug screen, excessive alcohol and tobacco use

- Gender: MALE
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treatment A (Type: ACTIVE_COMPARATOR): Viagra 50 mg tablet, administered with approximately 240 mL water under fasted conditions
- Treatment B (Type: EXPERIMENTAL): Sildenafil ODT tablet 50 mg, administered without water under fasted conditions
- Treatment C (Type: EXPERIMENTAL): Sildenafil ODT tablet 50 mg, administered with water under fasted conditions.

Based on this trial design, predict the completion outcome and termination type (if applicable).